Sawai Pharmaceutical Co. Ltd.’s $1.05 billion acquisition of Upsher?Smith Laboratories, Inc.

Sawai Pharmaceutical Co. Ltd. has signed an agreement to acquire the generic pharmaceuticals business of Upsher?Smith Laboratories, Inc., from its parent, ACOVA Inc. Upsher-Smith is a…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Ambrogio Visconti

This content is for Standard 1 Year members only.
Login Join Now